8 results
Anterior ischemic optic neuropathy (AION) - Recognition of giant cell arteritis (GCA)

1) Is visual loss caused
optic neuropathy (AION ... of GCA? ... Clinical manifestations ... #Rheumatology # ... Ophthalmology #Diagnosis #Algorithm
Clinical Disease Characteristics and Suggested Algorithm for Diagnostic Evaluation of Patients With Symptoms of Polymyalgia Rheumatica

#Diagnosis
Clinical Disease ... and Suggested Algorithm ... Patients With Symptoms ... #Diagnosis #Rheumatology ... #Algorithm #GCA
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Cell Arteritis (GCA ... Vasculitis Management Algorithm ... Guidelines • Visual Symptoms ... Without Visual Symptoms ... #rheumatology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
to 1:1 F:M • Clinical ... Constitutional symptoms ... & NPSLE rare, Malar ... Manifestations: Malar ... comparison #table #rheumatology
Antinuclear Antibodies (ANA)
ANA or Anti-NucIear Antibody refers to antibodies against antigens in the nucleus → like
healthy adults, and should ... context of other symptoms ... likely it will be clinically ... , Drug-induced Lupus ... ANA #patterns #rheumatology
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
) Suspect: Clinical ... Non-autoimmune rheumatologic ... Photosensitivity • Malar ... : • Symptoms limited ... Erythematosus #Diagnosis #Rheumatology
Polymyalgia Rheumatica (PMR) Diagnosis and Management Summary

WHAT?
 • Polymyalgia rheumatica (PMR) is a common systemic inflammatory
motion in the shoulders ... CLINICAL: • Physical ... diagnosed based on clinical ... symptoms. ... Diagnosis #Management #Rheumatology
Drug Induced Lupus (DIL)
 • Epidemiology: -10% of all lupus cases, drug-dependent, 4:1 to 1:1 F:M
to 1:1 F:M • Clinical ... Constitutional symptoms ... & NPSLE rare, Malar ... constitutional symptoms ... #DIL #rheumatology